Drug therapy for the orofacial and TMD pain patient.
Ganzberg
S
S
College of Dentistry & College of Medicine and Public Health, Ohio State University, USA.
D000700:Analgesics / Q000627:therapeutic use; D000701:Analgesics, Opioid / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D002908:Chronic Disease; D005157:Facial Pain / Q000188:drug therapy* / Q000209:etiology; D006261:Headache / Q000188:drug therapy; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy; D009437:Neuralgia / Q000188:drug therapy; D009465:Neuromuscular Agents / Q000627:therapeutic use; D010347:Patient Care Planning; D013705:Temporomandibular Joint Disorders / Q000188:drug therapy* / Q000209:etiology
D000700:Analgesics; D000701:Analgesics, Opioid; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000927:Anticonvulsants; D000929:Antidepressive Agents, Tricyclic; D009465:Neuromuscular Agents